Open Access

The evaluation of risk factors for recurrent hospitalizations resulting from wheezing attacks in preschool children

  • Sebnem Ozdogan1, 2Email author,
  • Burcu Tabakci1,
  • Ayse Sirin Demirel1,
  • Bilge Atli1,
  • Gulser Esen Besli3 and
  • Gulsen Kose1
Italian Journal of Pediatrics201541:91

DOI: 10.1186/s13052-015-0201-z

Received: 17 July 2015

Accepted: 11 November 2015

Published: 17 November 2015

Abstract

Background

We aimed to evaluate the risk factors in preschool children admitted to inpatient services with a diagnosis of recurrent attacks of wheezing.

Method

The medical files of 44 preschool children with 2 or more recurrent hospitalizations resulting from wheezing between November 2011 and January 2012 were retrospectively investigated.

Results

There were 28 males (64 %) and 16 females. The median age was 14 months (2.0–50). The median numbers of previous wheezing attacks and hospitalizations were 4 (2–10) and 2 (2–8), respectively. Fourteen patients (32 %) had been treated for gastroesophageal reflux (GER). The previous and recent hospital evaluations were investigated. Bronchopulmonary dysplasia and anemia were significantly more common in patients with 3 or more hospitalizations for wheezing than in those with 2 hospitalizations (p = 0.010 and p < 0.001, respectively). A review of the cases with 3 or more hospitalizations revealed that a history of GER and anemia were significant risk factors.

Conclusion

Anemia and GER are risk factors for recurrent hospitalizations resulting from wheezing and should be treated. If the history and physical examination suggest asthma, inhaler therapy treatment should be administered, with other investigations planned for patients who do not respond to treatment as expected.

Background

Recurrent wheezing attacks occurring during the pre-school period represent a significant healthcare concern and comprise one of the most common causes of emergency department visits and hospitalizations. The Children’s Respiratory Study (CRS) in Tucson reported a wheezing prevalence of 32 % during the first year of life, which decreased to 17.3 % at 2 years of age and to 12 % at 3 years of age [1]. One in three children experience at least one acute wheezing attack before the age of three years [2].

Recurrent wheezing impairs the quality of life for the patient and his/her family and causes a significant economic burden resulting from the healthcare expenses associated with the condition [35]. A phone call-based study by Bisgaard et al. detected the prevalence of recurrent wheezing among children between 1 and 5 years of age as 27 %, 29 % and 48 % in America, Northern Europe and Southern Europe, respectively. The rate of presentation to emergency departments and hospitalization was reported to be 16 % and 12 %, respectively, within the last 6 months [6].

A multinational study conducted in 17 centers in Latin America and Europe reported a wheezing ratio of 45.2 % and a recurrent wheezing prevalence of 20.3 % during the first year of life. The same study reported a rate of emergency department visits for wheezing of 71.1 % and a rate of hospitalization for recurrent wheezing of 26.8 % [7].

Whereas the most common cause of recurrent wheezing is asthma in all age groups, gastroesophageal reflux disease (GER), foreign body aspiration, bronchopulmonary dysplasia (BPD), bronchiolitis obliterans, an immunodeficiency, primary ciliary dyskinesia, vocal cord dysfunction, cardiac etiologies and structural abnormalities should be considered in the differential diagnosis [8]. A definitive diagnosis is based on invasive investigations such as radiological studies, laboratory values and bronchoscopy as well as the clinical history and physical examination. Because of the lack of consensus on the treatment for recurrent wheezing, many investigations could be conducted, and various treatments could be administered.

We evaluated the medical records of preschool children with a history of at least two hospitalizations resulting from attacks of wheezing.

Methods

The medical files of 44 children with two or more recurrent hospitalizations resulting from wheezing were retrospectively examined. The study was conducted in the Pediatric Inpatient Service at Sisli Hamidiye Etfal Training and Research Hospital between November 2011 and January 2012. We included children between 1 month and 5 years of age with complete records of at least 2 hospitalizations for wheezing. Children younger than 1 month and older than 5 years of age and those with incomplete or missing records were excluded. The demographics, previously requested investigations and current hospitalization records were investigated, as were the treatment approaches. The ethics committee of the hospital granted approval for the study.

Investigations

In patients with recurrent hospitalizations for wheezing, laboratory tests, imaging studies and, in some cases, bronchoscopy, were performed to aid the differential diagnosis. Detailed explanations of each of the tests performed in this study follow.

Blood tests

A hemogram, the total IgE values, specific IgE-inhalant allergens, specific IgE-food mixtures, and serum immunoglobulin count were obtained. For specific IgE-inhalant allergens, tree pollens, betula berrucosa, meadow pollens, weed pollens, house dust, dermatophagoides pteronyssinus, dermatophagoides farinae, fungi, yeast, mold and animal epithelia were investigated. For food mixtures, egg white, milk, fish (gadiformes), flour, peanut and soybeans were investigated. Anemia is defined as a hemoglobin level of less than the 5th percentile for age. The serum total IgE levels were determined to be normal or high based on the participants’ ages. Eosinophilia refers to an absolute eosinophil count in the peripheral blood of ≥ 500 eosinophils/microL/Specific IgE inhalant allergens and food allergens were determined to be normal or high, based on the reference values.

Radiological investigations

Chest radiography and, in selected patients, computed thoracic tomography were performed. The investigation results were assessed by a radiologist.

Purified protein derivative skin test

Purified protein derivative (PPD) skin testing was performed in the patients with a history of tuberculosis contact. The PPD solution was obtained from the Tuberculosis Dispensary in prefilled injectors and injected under appropriate conditions into the forearm of the patients via an intradermal route; the diameter of the induration occurring after 72 h was measured. For the patients without risk factors, an induration ≥ 15 mm was considered positive.

Sweat test

The sweat test was performed using the quantitative pilocarpine iontophoresis method in accordance with the international standards.

Esophageal pH monitoring

The patients underwent 24-h lower esophageal pH monitoring for longer than 18 h (ComforTec Plus Single Use Ph Prob, Sandhill Scientific, ZEPHR, USA). If the patient were receiving anti-reflux treatment, the drugs were discontinued 7 days before the investigation. The esophageal pH monitoring test results were considered to be abnormal when the time of pH ≤ 4.0 was greater than 6 % of the duration of the pH monitoring study for children over 1 year old and greater than 10 % for children younger than 1 year of age.

Echocardiography

Echocardiography (ECHO) was performed to assess the internal structure and functions of the heart via sound waves. A pediatric cardiologist assessed the results.

Chest computed tomography

Chest computed tomography (CT) was performed in selected patients to provide a detailed anatomy of the mediastinum, large airways, and lung parenchyma.

Flexible fiberoptic bronchoscopy

This investigation was performed by a pediatric pulmonologist under general operation room conditions using general or local anesthesia.

Statistical analysis

The descriptive properties of the variables were detected (the mean, median and frequency). The compliance of the variables with the normal distribution was checked. The Student’s t-test was used for the comparison of the variables with normal distribution. A comparison of the categorical variables was made using the chi-square test. Chi square testing (with the Fisher exact test where indicated by low expected cell counts) was used for this purpose. A univariate analysis was performed in the logistic regression analyses. The variables, which were p < 0.250 and considered potentially clinically significant, were included in the multivariate analysis, and a multiple logistic regression analysis was performed; p < 0.05 was considered significant. The Statistical Package for Social Sciences (SPSS) software, v. 17, (Chicago, USA) was used to evaluate the results.

Results

A total of 52 patients aged 1 month to 5 years with at least 2 recurrent hospitalizations resulting from wheezing were admitted during the study period. A total of 44 patients (16 females, 28 males) with complete medical records were enrolled in this study. The clinical characteristics of the patients are presented in Table 1. The median age was 14 months (2.0–50). Two patients (5 %) were below the 3rd percentile for height and weight. The median number of previous wheezing attacks and hospitalizations were 4 (2–10) and 2 [28], respectively. Eight of the patients were born prematurely (18 %), 14 (32 %) were admitted to the NICU, 7 (16 %) were intubated and 5 (11 %) were diagnosed with BPD. Fifteen patients (34 %) were breastfed for less than 6 months, and 25 patients (57 %) were bottle-fed at night. Fourteen patients (32 %) had been treated for GER. Twenty-one patients (48 %) had a parent or sibling with a history of asthma, allergic rhinitis or eczema, and 29 patients (66 %) had been exposed to smoke. The median number of people living in the same house as the patient was 4 (3–12). A review of the treatment regimens revealed that 9 patients (21 %) were treatment-naïve (with nebules), and only 10 had received nebule treatment. Fifteen patients used salbutamol syrup as prescribed.
Table 1

Clinical characteristics of patients, illustrating risk factors for recurrent wheezing

  

Median

Range

Age (months)

 

14

2.0–50

Number of recurrent wheezing attacks

 

4

2–10

Hospital admissions for recurrent wheezing

 

2

2–8

Number of people living in the same house

 

4

3–12

  

n

%

Sex (males)

 

28

64

Height and weight <3 %

 

2

5

Birth history

Prematurity

8

18

 

BPD*

5

11

 

NICU admission+

14

32

 

History of intubation

7

16

Breastfeeding <6 months

 

15

34

Nocturnal feeding

 

25

57

GER history

 

14

32

Inhaler use

Regular

10

23

 

naive

9

21

Salbutamol syrup

 

15

34

Smoking exposure

 

29

66

Parental asthma/AR/eczema

 

21

48

*Bronchopulmonary dysplasia, +Neonatal intensive care unit

The previous and recent hospital evaluations were investigated. The laboratory results are summarized in Table 2. Based on the hemograms obtained during the most recent hospitalization, 15 patients (34 %) were anemic, and 6 (14 %) had eosinophilia. Pulmonary radiography had been performed in all of the patients, and 23 (52 %) patients had infiltration/atelectasis. Immunoglobulins, including IgA, IgG and IgM were obtained in 38 (86 %) of the patients, and the levels were reported to be within the normal limits by age. Esophageal pH monitoring had been performed in 10 (23 %) patients, and 5 patients (50 %) were reported to have reflux. Two of the 30 patients who underwent echocardiography (7 %) were reported to have abnormal results. The immunoglobulin E level had been obtained in 39 (88 %) patients, 21(53 %) of whom had a high immunoglobulin E level. The inhalant panel was obtained for 31 patients and found to be positive for 3 patients (10 %). A PPD test was applied in 17 patients (39 %) with a positive tuberculosis contact history, and the results were negative. Ten patients (23 %) had undergone a sweat test, and the results for these patients were normal. Five of the patients undergoing chest CT (11 %) were reported to have infiltration. Three patients (7 %) had permanent wheezing and were non-responsive to nebule treatment; these patients underwent bronchoscopy, and no pathology, other than increased secretion, was reported.
Table 2

Summary of the results of investigations performed

Test

Subjects tested (%)

Abnormal results (%)

Hemogram

44/44 (100)

15/44 (34)–anemia

Eosinophilia

44/44 (100)

6/44 (14)

CXR

44/44 (100)

23/44 (52)–infiltration/atelectasis

IgA, IgG, IgM

38/44 (86)

0/38 (0)–below normal

IgE

39/44 (88)

21/39 (53)–high

Esophageal pH monitoring

10/44 (23)

5/10 (50)–findings consistent with reflux

Inhalant/food panel

31/44 (70)

3/31 (10)–positive

ECHO

30/44 (68)

2/30 (7)–abnormal

ppd

17/44 (38)

0/17 (0)–positive

Sweat test

10/44 (22)

0/10 (0)–positive

Chest CT

5/44 (11)

5/5 (100)–infiltration

FOB

3/44 (7)

3/3 (100)–increased secretions

CXR Chest X ray, Ig Immunglobulin, ECHO Echocardiography, ppd Purified protein derivative skin test, CT Computerized tomography, FOB Flexible fiberoptic bronchoscopy

The patients were divided into 2 groups as patients with 2 and patients with 3 or more hospitalizations. The risk factors and investigation results were compared (Table 3). The patients with 3 or more hospitalizations resulting from wheezing had a statistically significantly higher rate of BPD and anemia relative to the other group (p = 0.01 and p < 0.001, respectively).
Table 3

Comparison of the patients with 2 and patients with 3 or more hospitalizations due to recurrent wheezing attacks

 

2

3 or more

 

n: 24

n: 20

 

n (%)

n (%)

p

Gender (male)

14 (58)

15 (%75)

*0.34

Age(months), mean

19.7 ± 14.3

17.0 ± 10.6

^0.48

History of NICUa admission

5 (21)

9 (45)

*0.16

History of intubation

2 (8)

5 (25)

*0.13

BPDb

0 (0)

5 (25)

*0.01**

GERc

5 (21)

9 (45)

*0.16

Preterm delivery

3 (13)

5 (25)

*0.29

Nocturnal feeding

14 (58)

11 (55)

*1.00

Nocturnal feeding

14 (58)

11 (55)

*1.00

Pathologic pH monitoring

2 (8)

3 (15)

*0.34

IgE level (high)

10 (42)

8 (40)

*0.57

Abnormal CXRd

13 (54)

10 (50)

*1.00

Abnormal Chest CTe

1 (4)

4 (20)

*0.16

Positive inhalant/food panel

1 (4)

2 (10)

*0.77

Eosinophilia

3 (13)

3 (15)

*1.00

Anemia

3 (13)

12 (60)

* < 0.00**

Parenteral asthma/eczema/ARf

8 (33)

5 (25)

*0.78

ICSg use

16 (67)

14 (70)

*1.00

Exposure to smoking

15 (63)

14 (70)

*0.83

Neonatal intensive care unita , Bronchopulmonary dysplasiab, Gastroesophageal refluxc , Chest Xrayd, Computed tomographye, Allergic rhinitisf, Inhaler corticosteroid’g

^Results expressed as mean ± SD (student’s t-test). Chi-square test or Fisher’s exact test. **Statistically significant

Table 4 reveals the risk factors of the patients with 3 or more hospitalizations. The multivariate regression analysis revealed that the odds ratio for hospitalization resulting from a history of GER and the presence of anemia is 6.29 and 17.03, respectively.
Table 4

Multivariate logistic regression analysis showing the risk factors for 3 or more hospitalization for wheezing attacks

 

Adjusted OR

CI 95 %

p

Anemia

17.02

3.03–95.44

0.00

GER

6.28

1.99–33.33

0.03

CI Confidence interval, OR Odds ratio, GER Gastroesophageal reflux

Discussion

Because of the lack of consensus on the description, assessment and treatment of recurrent wheezing in young children, these cases are quite difficult for clinicians to manage. Many unnecessary investigations are conducted, and inadequate treatment is provided. We investigated the demographics, the requested investigations, and the results for pre-school children with recurrent hospitalizations resulting from wheezing. A comparison of the patients with 2 and the patients with 3 or more hospitalizations resulting from wheezing revealed that the patients with 3 or more hospitalizations had a statistically significantly higher rate of BPD and anemia relative to the other group. The regression analysis revealed that a GER history and presence of anemia were significant risk factors in patients with 3 or more hospitalizations resulting from wheezing.

Several studies have reported that boys have an increased risk of early persistent wheezing and allergic sensitization [9, 10]. In our study, 64 % of the patients with recurrent wheezing attacks were boys.

Breastfeeding protects against respiratory infections during the early period of life. However, the relationship between breastfeeding and wheezing has not been elucidated [11]. Whereas there are clinical studies suggesting that breastfeeding is protective against wheezing, other studies have not detected an association. We failed to detect an association between breastfeeding and recurrent wheezing, although 34 % of the patients were breastfed for less than 6 months, which is most likely because of the small sample size.

Passive smoking has a strong correlation with respiratory complaints [12]. In this study, we detected a rate of passive smoking as high as 66 %; however, we failed to show passive smoking as a risk factor in patients with 3 or more hospitalizations resulting from wheezing. In the British Cohort Study, a strong correlation was demonstrated between maternal smoking and the presence of wheezing during early childhood; however, such a correlation could not be shown for the subsequent period [13]. The Tucson CRS study suggested that maternal prenatal smoking affects in utero lung function and increases the risk of wheezing during the first 3 years of life [14]. A recent mother and child cohort study in Norway reported that smoking by the grandmother while pregnant with the mother increases the risk of asthma in the grandchild, independent of the maternal smoking status [15]. In this study, we did not investigate the history of smoking during pregnancy.

A review of the cases with 3 or more hospitalizations for wheezing revealed that the presence of anemia increased the risk of hospitalization 17.02 fold. The studies investigating the association between anemia and lower respiratory infections are limited. Iron deficiency anemia affects the immune response and alters the metabolism of pathogens. A low tissue hemoglobin level impairs tissue oxygenation and represents a risk for lower respiratory infections in children [16]. The literature data suggest that the presence of anemia increases the risk of acute lower respiratory infection 3 to 6 fold [16, 17]. In a randomized, controlled study in Sri Lanka, iron supplementation reduced morbidity in children with and without an upper respiratory tract infection [18]. There are studies suggesting that maternal anemia during pregnancy is a risk factor for recurrent wheezing [19]. Maternal anemia was not investigated in our study.

Reviewing the patients with recurrent hospitalizations resulting from wheezing, we observed that the presence of GER increased the risk of 3 or more hospitalizations 6.29 fold. In our study, 14 patients had been on GER treatment, and 5 of the 14 had abnormal pH monitoring results. The presence and treatment of GER has a significant role in recurrent wheezing. A systematic review of the clinical studies conducted between 1966 and 2008 revealed a mean GER prevalence of 20 % (ranging from 19.3 to 80 %) in children with asthma [20]. A study investigating the association between the recurrence of respiratory symptoms and GER detected GER in 35 % of the patients, which included 40 % of the enrolled cases of reactive airway disease. In the same study, the respiratory complaints had started below the age of one in 86 % of the patients with GER. A marked reduction in wheezing was observed 3–6 months after anti-reflux treatment [21]. Empiric GER treatment would be an appropriate approach in patients with recurrent hospitalizations resulting from wheezing and in cases of no response or an inadequate response to ICS treatment.

Patra et al. found that 42 % of the patients below the age of 1 with wheezing had positive GER investigations. They report that GER is a significant cause of recurrent wheezing in patients below 2 years of age and recommend GER investigations in patients with severe attacks having an onset below the age of 1 year [22]. A trial by Sheikh et al. detected silent chronic aspiration secondary to difficulty of swallowing without GER in 13 infants with chronic respiratory symptoms [23].

Consensus was not achieved on the description, assessment and treatment of wheezing in pre-school children; however, a trial of ICS and montelukast treatment in patients with recurrent wheezing, with discontinuation of treatment in non-responders, was recommended [24].

In an observational study by Saglani et al., invasive tests, including computed chest tomography, blood tests, a nasal cilia biopsy, flexible bronchoscopy with bronchoalveolar lavage, and pH monitoring, were performed in 47 patients, between 3 months and 5 years of age, who experienced recurrent wheezing despite ICS treatment. One-third of the patients had abnormal investigation results, and these patients were diagnosed with an airway abnormality, GER, eosinophilic airway inflammation, and bacterial infection [25]. In our study, 80 % of the patients had not received previous ICS treatment or were not using the therapy regularly.

Regardless of the age at onset, atopic findings, triggering factors or the frequency of wheezing, the most common cause of recurrent wheezing is asthma [26]. A study in Finland suggested that, based on a 6-month follow-up, more than one-third of children below 2 years of age, hospitalized for wheezing, were diagnosed with asthma, and the risk was high, particularly in those with recurrent wheezing and allergic findings [27].

Salbutamol syrup remains in use for the treatment of wheezing. Whereas the Global Initiative for Asthma (GINA) and National Asthma Education and Prevention Program (NAEPP) consensus reports do not include salbutamol syrup in the treatment protocol for asthma for patients below 5 years of age, the syrup is frequently used in the treatment of wheezing [2831]. Whereas salbutamol syrup should not be used because of the absence of efficacy for the treatment of wheezing and the presence of side effects, this treatment remains in use because of economic reasons and the societal prejudice against inhaled treatments [32]. Physicians have a great role in the implantation of treatment protocols through efforts to inform society and establishing consensus reports.

Considering that the study was conducted in winter and that one-half of the pulmonary radiography investigations were reported as increased ventilation and infiltration/atelectasis, the most likely cause of wheezing was infection. We were unable to perform a respiratory viral panel. There were 14 patients with GER findings (31.8 %), and 5 patients (11.4 %) had esophageal pH monitoring results consistent with reflux. The sensitivity, specificity and clinical utility of pH monitoring for extra esophageal indications are not well established.

The high serum IgE level, eosinophilia, inhalant/food panel detected in 53 %, 14 %, and 10 % of the patients, respectively, suggest the presence of changes secondary to infection rather than an atopic background. An increased serum IgE level might be associated with an acute viral infection in atopic and non-atopic children [33]. IgE production is secondary to an inflammatory process occurring in the asthmatic airway rather than to a specific allergen [34]. The presence of eosinophilia might be explained by parasitosis as well as atopy. Of the other tests requested, the immunoglobulin panel, PPD, sweat test and ECHO investigation yielded normal results in a larger portion of patients. The low frequency of the diagnoses of immunodeficiency, cystic fibrosis and cardiac abnormality that should be considered in the differential diagnosis of recurrent wheezing might be attributed to the small number of patients. If the number of the patients were larger, we could hypothesize that the probability of diagnosing the above conditions would increase.

The strength of our study is that it is the first to assess the risk factors for 2 or more recurrent hospitalizations resulting from wheezing. An important limitation of this retrospective study results from missing data, incomplete data, unknown confounders, and the small sample size.

Conclusion

Anemia and GER are risk factors for recurrent hospitalizations for wheezing and should be treated. In cases of recurrent wheezing, the investigations to be performed are quite limited if the history and the physical examination are not atypical. Various non-invasive and invasive investigations are increasingly performed to rule out other potential pathologies and as a measure against malpractice claims. Most of these investigations are unnecessary and expensive and lead to radiation and trauma to children. If the physical examination and history are not abnormal, an ICS trial should be administered, with further investigations planned for non-responders; this protocol would be more appropriate than requesting investigations to rule out potential diagnoses.

Declarations

Acknowledgements

The authors would like to thank Dr Nuray Uslu Kizilkan, Dr Merve Usta and Dr Nafiye Urganci, Pediatric Gastroenterology, Sisli Hamidiye Etfal Research and Training Hospital, Istanbul for suggestions and comments.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Sisli Hamidiye Etfal Research and Training Hospital
(2)
Sinan Ercan Sok, Isiklar 1 Apt. No 34, Da: 23, 34742
(3)
Istanbul Medeniyet University, Faculty of Medicine

References

  1. Wright AL. Epidemiology of asthma and recurrent wheeze in childhood. Clin Rev Allergy Immunol. 2002;22:33–44.View ArticlePubMedGoogle Scholar
  2. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson children’s respiratory study: 1980 to present. J Allergy Clin Immunol. 2003;111:661–75.View ArticlePubMedGoogle Scholar
  3. De Jong BM, van der Ent CK, van Putte KN, van der Zalm MM, Verheij TJ, Kimpen JL, et al. Determinants of healthcare utilization for respiratory symptoms in the first year of life. Med Care. 2007;45:746–52.View ArticlePubMedGoogle Scholar
  4. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J. 2003;21:1000–6.View ArticlePubMedGoogle Scholar
  5. Zar HJ, Ferkol TW. The global burden of respiratory disease-impact on child health. Pediatr Pulmonol. 2014;49:430–4.View ArticlePubMedGoogle Scholar
  6. Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol. 2007;42:723–8.View ArticlePubMedGoogle Scholar
  7. Mallol J, García-Marcos L, Solé D, Brand P, EISL Study Group. International prevalence of recurrent wheezing during the first year of life:variability, treatment patterns and use of health resources. Thorax. 2010;65:1004–9.View ArticlePubMedGoogle Scholar
  8. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383:1593–604.View ArticlePubMedGoogle Scholar
  9. Melen E, Kere J, Pershagen G, Svartengren M, Wickman M. Influence of male sex and parental allergic disease on childhood wheezing: role of interactions. Clin Exp Allergy. 2004;34:839–44.View ArticlePubMedGoogle Scholar
  10. Garcia-Marcos L, Mallol J, Solé D, Brand PL, EISL Study Group. International study of wheezing in infants: risk factors in affluent and non-affluent countries during the first year of life. Pediatr Allergy Immunol. 2010;21:878–88.View ArticlePubMedGoogle Scholar
  11. Kramer MS, Matush L, Vanilovich I, Platt RW, Bogdanovich N, Sevlovskaya Z, et al. Shapiro S; PROBIT Study Group. Effects of prolonged and exclusive breastfeeding on child height, weight, adiposity, and blood pressure at age 6.5 y: evidence from a large randomized trial. Am J Clin Nutr. 2007;86(6):1717–21.PubMedGoogle Scholar
  12. Gilmour MI, Jaakkola MS, London SI, Nel AE, Rogers CA. How exposure t environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ Health Perspect. 2006;114:627–33.View ArticlePubMed CentralPubMedGoogle Scholar
  13. Lewis S, Richards D, Bynner J, Butler N, Britton J. Prospective study of risk factors for early and persistent wheezing in childhood. Eur Respir J. 1995;8:349–56.View ArticlePubMedGoogle Scholar
  14. Stein RT, Holberg CJ, Sherrill D, Wright AL, Morgan WJ, Taussig L, et al. Influence of parental smoking on respiratory symptoms during the firstdecade of life: the Tucson Children’s Respiratory Study. Am J Epidemiol. 1999;149:1030–7.View ArticlePubMedGoogle Scholar
  15. Magnus MC, Haberg SE, Karlstad Ø, Nafstad P, London SJ, Nystad W. Grandmother’s smoking when pregnant with the mother and asthma in the grandchild: the Norwegian Mother and Child Cohort Study. Thorax. 2015;70:237–43.View ArticlePubMedGoogle Scholar
  16. Ramakrishnan K, Harish PS. Hemoglobin level as a risk factor for lower respiratory tract infections. Indian J Pediatr. 2006;73:881–3.View ArticlePubMedGoogle Scholar
  17. Hussain SQ, Ashraf M, Wani JG, Ahmed J. Is Low Hemoglobin Level a Risk Factor for Acute Lower Respiratory Tract Infections? J Clin Diagn Res. 2014;8.
  18. de Silva A, Atukorala S, Weerasinghe I, Ahluwalia N. Iron supplementation improves iron status and reduces morbidity in children with or without upper respiratory tract infections: a randomized controlled study in Colombo, Sri Lanka. Am J Clin Nutr. 2003;77:234–41.PubMedGoogle Scholar
  19. Triche EW, Lundsberg LS, Wickner PG, Belanger K, Leaderer BP, Bracken MB. Association of maternal anemia with increased wheeze and asthma in children. Ann Allergy Asthma Immunol. 2011;106:131–9.View ArticlePubMed CentralPubMedGoogle Scholar
  20. Thakkar K, Boatright RO, Gilger MA, El-Serag HB. Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010;125:925–30.View ArticleGoogle Scholar
  21. Jain A, Patwari AK, Bajaj P, Kashyap R, Anand VK. Association of gastroesophageal reflux disease in young children with persistent respiratory symptoms. J Trop Pediatr. 2002;48:39–42.View ArticlePubMedGoogle Scholar
  22. Patra S, Singh V, Chandra J, Kumar P, Tripathi M. Gastro-esophageal reflux in early childhood wheezers. Pediatr Pulmonol. 2011;46:272–7.View ArticlePubMedGoogle Scholar
  23. Sheikh S, Allen E, Shell R, Hruschak J, Iram D, Castile R, et al. Chronic aspiration without gastroesophageal reflux as a cause of chronic respiratory symptoms in neurologically normal infants. Chest. 2001;120:1190–5.View ArticlePubMedGoogle Scholar
  24. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32:1096–110.View ArticlePubMedGoogle Scholar
  25. Saglani S, Nicholson AG, Scallan M, Balfour-Lynn I, Rosenthal M, Payne DN, et al. Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur Respir J. 2006;27:29–35.View ArticlePubMedGoogle Scholar
  26. Lasso-Pirot A, Delgado-Villalta S. AJ Spainer. Early childhood wheezers: identifying asthma in later life. J Asthma Allergy. 2015;8:63–73.PubMed CentralPubMedGoogle Scholar
  27. Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi M. Wheezing requiring hospitalization in early childhood: predictive factors for asthma in a six-year follow-up. Pediatr Allergy Immunol. 2002;13:418–25.View ArticlePubMedGoogle Scholar
  28. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. Geneva: World Health Organization; 2005. (available at: http://www.who.int/childadolescent-health/New_Publications/CHILD_HEALTH/PB/00.PB_full_low.pdf)
  29. Global Initiative for Asthma: Global strategy for the diagnosis and management of asthma in children 5 years and younger [Internet] 2009. Available from: www.ginasthma.org.
  30. NIH. National Asthma Education and Prevention Program. Expert Panel Report III: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; National Heart, Lung, and Blood Institute; 2007. NIH Publication No. 07-4051.
  31. Bonner S, Matta T, Rubin M, Fagan J, Ahern J, Evans D. Oral b2‐Agonist Useby Preschool Children with Asthma in East and Central Harlem, New York. J Asthma. 2006;43:31–5.View ArticlePubMedGoogle Scholar
  32. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2006;19(3):CD001266.
  33. Yilmaz O. Clinical significance of elevated serum total IgE: Review. Turkiye Klinikleri J Pediatr. 2015;24:8–14.View ArticleGoogle Scholar
  34. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child. 1995;72:317–20.View ArticlePubMed CentralPubMedGoogle Scholar

Copyright

© Ozdogan et al. 2015

Advertisement